Mode
Text Size
Log in / Sign up

Impact of Visceral Obesity on Surgical Outcomes in Colorectal Cancer ResectionVisceral obesity linked to surgical complications in colorectal cancer cases

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Visceral obesity increases surgical complexity and morbidity but does not impact long-term survival in colorectal cancer.

This meta-analysis involving 6,500 patients provides a comprehensive evaluation of how visceral obesity influences clinical outcomes following the surgical resection of colorectal cancer. The study specifically examines the correlation between visceral fat distribution and various intraoperative and postoperative metrics to determine the impact on surgical complexity and patient recovery.

Intraoperatively, the presence of visceral obesity is associated with significant technical challenges. The data indicate that these patients experience significantly prolonged operative times and higher volumes of intraoperative blood loss. Furthermore, there is a documented increase in the rates of conversion to open laparotomy, suggesting that the presence of excessive visceral fat complicates the surgical field and necessitates more complex maneuvers during the procedure.

Postoperative complications are notably higher in patients with visceral obesity. Specifically, these patients face increased incidences of incisional wound infections and anastomotic leakage. These findings suggest that visceral obesity contributes to a more difficult recovery period and higher risk of immediate surgical complications, likely due to compromised tissue quality or increased inflammatory responses associated with adipose tissue.

Despite the increased technical difficulty and higher rates of immediate complications, the study found no statistically significant differences in several critical long-term outcomes. Specifically, postoperative mortality, positive surgical margin rates, and time to first flatus were not significantly affected by the presence of visceral obesity. This suggests that while the surgical experience is more arduous, the immediate physiological milestones of recovery remain comparable.

From an oncological perspective, the meta-analysis indicates that visceral obesity does not appear to compromise long-term survival metrics. There were no statistically significant differences in 5-year disease-free survival or 5-year overall survival between patients with and without visceral obesity. This distinction is vital for clinicians to understand that while the surgical path is more complex, the primary oncologic goals remain achievable. In conclusion, visceral obesity serves as a significant predictor of intraoperative difficulty and postoperative morbidity in colorectal cancer surgery. While it necessitates greater surgical vigilance and resources to manage complications like anastomotic leakage and wound infections, it does not appear to negatively impact long-term survival or oncologic success. Clinicians should prepare for more demanding operative environments when managing patients with high visceral fat content.

How this fits prior evidence

This meta-analysis addresses the impact of visceral obesity on surgical outcomes in colorectal cancer. While it does not directly relate to the findings on multimodal prehabilitation, nutritional management, or imaging techniques like PET/CT and Node-RADS, it provides critical data on how patient-specific physical characteristics like visceral fat influence surgical complexity and postoperative morbidity. Specifically, it confirms that while visceral obesity increases intraoperative difficulty and complication rates, it does not appear to impact long-term survival outcomes.

For people facing surgery for colorectal cancer, the physical challenges of the procedure are a major concern. One specific factor that can impact the surgical experience is visceral obesity. This refers to fat stored deep in the abdominal cavity. Understanding how this type of weight affects surgery can help patients and doctors prepare for the recovery process and manage expectations regarding surgical complications.

Researchers conducted a large-scale meta-analysis to look at the impact of visceral obesity on patients undergoing surgery to remove colorectal cancer. The study included data from 6,500 patients. By comparing patients with visceral obesity to those without it, the researchers aimed to see if abdominal fat changed how difficult the surgery was or how well the patient recovered in the immediate weeks following the operation.

The findings showed that patients with visceral obesity faced more challenges during the actual surgery. These patients had longer operative times and experienced more blood loss during the procedure. Additionally, there were higher rates of conversion to open laparotomy, which means the surgery had to be changed to a more invasive method. After the surgery, these patients were more likely to experience complications, such as wound infections and anastomotic leakage (a leak at the site where the intestine is joined). They also required longer stays in the hospital. However, the study did not find a significant difference in the number of lymph nodes harvested or the rate of positive surgical margins.

Importantly, the study found that visceral obesity did not appear to change long-term outcomes. There were no significant differences in the five-year disease-free survival rates or the overall survival rates for patients with and without visceral obesity. Other factors, such as the time to first flatus (passing gas) and the risk of urinary dysfunction, also showed no significant differences between the two groups.

It is important to remember that this is a meta-analysis, which combines data from many studies to find general trends. While the link between visceral obesity and immediate surgical complications is clear, it does not mean that visceral obesity changes the ultimate success of the cancer treatment. For patients today, this means that while the surgical path may be more technically difficult for those with visceral obesity, the long-term outlook for cancer survival remains consistent. Patients should discuss these specific surgical risks with their surgical team to prepare for the recovery period.

What this means for you:
Visceral obesity can make colorectal surgery more difficult and increase short-term complications without affecting long-term survival.

Study Details

Study typeMeta analysis
Sample sizen = 6,500
EvidenceLevel 1
Follow-up60.0 mo
PublishedSep 2026
View Original Abstract ↓
Obesity is closely associated with the initiation and progression of colorectal cancer (CRC) and is widely recognized as a risk factor for unfavorable surgical outcomes. Nevertheless, the extent to which visceral obesity specifically influences perioperative safety and long-term oncologic outcomes following CRC resection remains to be established. We performed a systematic review and meta-analysis by comprehensively searching PubMed, Web of Science, Embase, Scopus, and the Cochrane Library. Continuous, dichotomous, and survival-related variables were synthesized using weighted mean difference (MD) or standardized MD (SMD), odds ratios (ORs), and hazard ratios (HRs), respectively. A total of 23 studies comprising 6,500 patients were included. Relative to patients without visceral obesity, those with visceral obesity demonstrated significantly prolonged operative time, greater intraoperative blood loss, higher rates of conversion to open laparotomy, increased overall postoperative complication rates, higher incidences of incisional wound infection and anastomotic leakage, a reduced number of harvested lymph nodes, and extended postoperative hospital stay. In contrast, no statistically significant differences were identified in postoperative mortality, positive surgical margin rates, time to first flatus, urinary dysfunction, 5-year disease-free survival, or 5-year overall survival. Collectively, these findings indicate that visceral obesity substantially increases intraoperative technical difficulty and postoperative morbidity; however, it does not appear to compromise long-term oncologic outcomes following CRC resection.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.